Created at Source Raw Value Validated value
Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: written or witnessed verbal informed consent from patient or remote legal authorized representative (lar) or remote family member as permitted by governing local or central institutional review board (irb)/independent ethic committee (iec). male or female 18-85 years old hospitalized covid-19 patients (positive local sars-cov2 test) receiving oxygen (o2) by face mask or nasal cannula/prongs and/or with elevated markers of cardiac injury or dysfunction (hstni or nt-probnp) as assessed by local testing

inclusion criteria: written or witnessed verbal informed consent from patient or remote legal authorized representative (lar) or remote family member as permitted by governing local or central institutional review board (irb)/independent ethic committee (iec). male or female 18-85 years old hospitalized covid-19 patients (positive local sars-cov2 test) receiving oxygen (o2) by face mask or nasal cannula/prongs and/or with elevated markers of cardiac injury or dysfunction (hstni or nt-probnp) as assessed by local testing

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: 1. written or witnessed verbal informed consent from patient or remote legal authorized representative (lar) or remote family member as permitted by governing local or central institutional review board (irb)/independent ethic committee (iec). 2. male or female 18-85 years old hospitalized covid-19 patients (positive local sars-cov2 test) 3. receiving oxygen (o2) by face mask or nasal cannula/prongs and/or with elevated markers of cardiac injury or dysfunction (hstni or nt-probnp) as assessed by local testing

inclusion criteria: 1. written or witnessed verbal informed consent from patient or remote legal authorized representative (lar) or remote family member as permitted by governing local or central institutional review board (irb)/independent ethic committee (iec). 2. male or female 18-85 years old hospitalized covid-19 patients (positive local sars-cov2 test) 3. receiving oxygen (o2) by face mask or nasal cannula/prongs and/or with elevated markers of cardiac injury or dysfunction (hstni or nt-probnp) as assessed by local testing